Upgrade to SI Premium - Free Trial

H.C. Wainwright Reiterates Buy Rating on Autolus Therapeutics plc (AUTL)

April 30, 2026 6:55 AM
H.C. Wainwright analyst Emily Bodnar reiterated a Buy rating and $9.00 price target on Autolus Therapeutics plc (NASDAQ: AUTL).The analyst ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments